Author Archives: Forest Ray PhD

COVID-19 Poses Greater Risk to Hospitalized Patients

People with Parkinson’s disease who are hospitalized with COVID-19 may have a greater risk for more severe infections and higher mortality, according to a recent study of German hospital records. The study, “Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson’s Disease in Germany,” was published…

Korean Study Ties Air Pollution to Developing Parkinson’s

Nitrogen dioxide (NO2) is associated significantly with a higher risk for developing Parkinson’s disease, according to a recent study from Korea. The finding reinforces previous research showing a potential link between air pollution and Parkinson’s. The results also prompted researchers to suggest that better air pollution regulations might lower…

Ketamine Advances as Treatment for Levodopa-induced Dyskinesia

The U.S. Food and Drug Administration (FDA) has approved PharmaTher‘s investigational new drug (IND) application for ketamine as a treatment for levodopa-induced dyskinesia in people with Parkinson’s disease. The approval clears the way for PharmaTher to proceed with a Phase 2 clinical trial to study low-dose ketamine —…

Anxiety May Be Unique for Each Patient

Anxiety appears to worsen the physical and cognitive symptoms of Parkinson’s disease, despite the various ways that individuals experience it, according to a recent study. Researchers and healthcare professionals, the study concluded, should take these personal experiences into account when crafting both individual therapies and future research. The study,…

Partnership Seeks to Develop New Therapies

Alligator Bioscience and BioArctic AB have partnered to research and develop new therapies for neurodegenerative disorders such as Parkinson’s disease and Alzheimer’s. “We are very pleased that BioArctic has recognized the power of Alligator’s proprietary phage display libraries which have been successfully used to generate Alligator’s…

ROPAD Study of Parkinson’s Genetics Enrolling 2,500 More Patients

Centogene announced plans to recruit 2,500 more patients this year into its observational Rostock International Parkinson’s Disease (ROPAD) study of how genetic factors contribute to the development of Parkinson’s. “We recently reached a significant study milestone, but this is just the beginning,” Peter Bauer, MD, Centogene’s chief genomic…

New ‘NeuroInsight’ Fellowship Program Awarded €4.7M

A new research training program called NeuroInsight is seeking to teach scientists in the data analytics and neuroscience skills needed to research Parkinson’s disease and other neurological conditions. The program received a €4.7 million ($5.64 million) grant from the Marie Skłodowska-Curie Actions COFUND, a European fund that provides financial…

Neuroticism May be Parkinson’s Risk Factor

The personality trait neuroticism correlates with a higher risk of developing Parkinson’s disease, according to recent research. The study, “Neuroticism and Risk of Parkinson’s Disease: A Meta-Analysis,” was published in the journal Movement Disorders. Neuroticism refers to an individual’s tendency to experience negative emotions, self-consciousness, vulnerability…

Ask an expert survey graphic

Your Parkinson’s Community

Woman laying down illustration

Visit the Parkinson’s News Today forums to connect with others in the Parkinson’s community.

View Forums